Belite Bio, Inc. ADR (BLTE) Stock Research

Belite Bio, Inc. ADR

· BLTE

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

6.839 B

-2.10%

Today

Belite Bio management to meet with Piper Sandler

BLTE

5:32 PM

Over a week ago

Belite Bio price target raised by $14 at Mizuho, here's why

BLTE

Sep 9, 7:21 AM

Belite Bio price target raised by $31 at H.C. Wainwright, here's why

BLTE

Sep 8, 8:54 AM

Belite Bio submits NDA to MHLW in Japan for tinlarebant in STGD1

BLTE

Sep 8, 6:04 AM

UiPath downgraded, Shell upgraded: Wall Street's top analyst calls

+12

Sep 4, 9:48 AM

Canaccord starts Belite Bio at Buy on additional post-IPO upside

BLTE

Sep 4, 6:29 AM

Belite Bio initiated with bullish view at Canaccord

BLTE

Sep 4, 5:16 AM

Belite Bio price target raised by $5 at Morgan Stanley

BLTE

Aug 17, 8:56 AM

Belite Bio price target raised by $5 at Morgan Stanley, here's why

BLTE

Aug 14, 8:34 AM

Belite Bio price target raised by $4 at Cantor Fitzgerald, here's why

BLTE

Aug 14, 8:00 AM

Belite Bio price target raised by $5 at Mizuho, here's why

BLTE

Aug 14, 7:21 AM

Morning Movers: Cerebras slides following quarterly results

+13

Aug 13, 8:58 AM

Belite Bio reports Q2 EPS (54c), consensus (78c)

BLTE

Aug 13, 5:21 AM

Belite Bio price target raised by $14 at H.C. Wainwright, here's why

BLTE

Aug 12, 6:12 AM

Belite Bio announces FDA acceptance, priority review of tinlarebant NDA

BLTE

Aug 11, 4:40 PM

Belite Bio completes rolling submission of NDA to U.S. FDA for tinlarebant

BLTE

Jun 14, 4:26 PM

Belite Bio price target lowered by $8 at Mizuho, here's why

BLTE

May 26, 8:19 AM

Belite Bio reports Q1 non-GAAP EPS (34c), consensus (64c)

BLTE

May 20, 6:08 AM

Belite Bio receives orphan drug status for tinlarebant in Switzerland

BLTE

May 18, 4:04 PM

Belite Bio management to meet wit Cantor

BLTE

Apr 29, 5:14 PM

Belite Bio initiates rolling submission of NDA to U.S FDA for tinlarebant

BLTE

Apr 21, 4:03 PM

Belite Bio price target raised by $15 at H.C. Wainwright, here's why

BLTE

Mar 3, 12:16 PM

Belite Bio price target raised by $30 at Benchmark, here's why

BLTE

Mar 3, 8:22 AM

Belite Bio price target raised by $66 at Cantor Fitzgerald, here's why

BLTE

Mar 3, 8:17 AM

Belite Bio price target raised by $10 at Morgan Stanley, here's why

BLTE

Mar 3, 8:11 AM

Charts